Skip to main content
Caplight Logo









Demeetra AgBio

Demeetra AgBio

Private
Lexington, KentuckyHealthcare & Life Scienceshttps://demeetra.com/

Last Round

Convertible Debt

Apr 1, 2021

Company Overview

Demeetra AgBio is a biotechnology company that develops advanced genome engineering platforms and integrated services for biopharmaceutical and industrial applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

gene editinggenome engineeringcell line developmentCLDCas-CLOVERbiomanufacturingCRISPR alternativetransposon technologybiologics productionpiggyBacCHO cell linesbiotech licensinggene therapy researchCDMOsynthetic biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Demeetra AgBio Comparables

Compare Demeetra AgBio with similar companies based on industry and business-model similarity.

Demeetra AgBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Integra Therapeutics
77%
Bio-Techne Corporation
71%
SIRION Biotech
69%

Demeetra AgBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtApr 1, 2021

Key People

Founding team and executive leadership

Jack Crawford

Chief Executive Officer

Executive Team

Demeetra AgBio Investors

Notable investors and investment history

Demeetra AgBio investors
InvestorRounds
Rapha Capital ManagementConvertible Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Grew 21% QoQ, from 14 to 17 employees.

  • May 12, 2026

    Monthly visitors grew 80% MoM, reaching 4K.

Recent news

Latest coverage and updates

  • launchesSep 19, 2026

    Demeetra AgBio, Inc. launches Harbor-IN Elite.

Demeetra AgBio Filings

Explore SEC and related filing metadata, where available.

Demeetra AgBio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Demeetra AgBio's valuation, stock price, and market status.

Is Demeetra AgBio a public or private company?

Demeetra AgBio is a private company.

What is the current stock price of Demeetra AgBio?

Demeetra AgBio is a private company with no public stock price. No recent secondary market data is available.

How much is Demeetra AgBio worth (valuation)?

Valuation information for Demeetra AgBio is not publicly available.

Can I buy Demeetra AgBio stock?

Demeetra AgBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Demeetra AgBio's last funding round?

Demeetra AgBio's most recent funding round was Convertible Debt on April 1, 2021.

Who are the main investors in Demeetra AgBio?

Key investors in Demeetra AgBio include Rapha Capital Management.

Will Demeetra AgBio IPO soon?

No public IPO plans have been announced for Demeetra AgBio.

How can I track Demeetra AgBio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Demeetra AgBio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLexington, Kentucky
Employee Range15
Year Founded2019
Last FundingApr 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?